Diagnostic surgical pathology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition)

Chest

Volumn 132, Issue 3 SUPPL., 2007, Pages 78S-93S

  Schwartz, Arnold M ^a   Henson, Donald E ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Immunohistochemistry; Mesothelioma; Non small cell carcinoma; Pathology; Small cell carcinoma; Squamous cell carcinoma

Indexed keywords

ARTICLE; CANCER INVASION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; EVIDENCE BASED MEDICINE; HUMAN; LUNG CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; TUMOR VOLUME; CANCER STAGING; CYTODIAGNOSIS; IMMUNOHISTOCHEMISTRY; LUNG TUMOR; METHODOLOGY; PATHOLOGY; PEROPERATIVE CARE; PROGNOSIS;

CYTODIAGNOSIS; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE CARE; LUNG NEOPLASMS; NEOPLASM STAGING; PROGNOSIS;

EID: 34848850479     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.07-1350     Document Type: Article

References (95)

1. World Health Organization. Tumors of the lung, pleura, thymus and heart. In: Travis WD, Brambilla E, Muller-Hermelink HK, et al, eds. Classification of tumors. Lyon, France, IARC Press, 2004; 9-124
2. Franklin WA. Diagnosis of lung cancer. Chest 2000; 117(suppl 1):80S-89S
3. Buccheri G, Ferrigno D. Prognostic value of stage grouping and TNM descriptors in lung cancer. Chest 2000; 117:1247-1255
4. Lababede O, Meziane MA, Rice TW. TNM staging of lung cancer. Chest 1999; 115:233-235
5. Travis WD. Lung. In: Henson D, Albores-Saavedra J, eds. Pathology of incipient neoplasia. 3rd ed. New York, NY: Oxford University Press, 2001; 295-318
6. Johnston WW. Fine needle aspiration biopsy versus sputum and bronchial material in the diagnosis of lung cancer: a comparative study of 168 patients. Acta Cytol 1988; 32:641-646
7. Petty TL. The early identification of lung cancer by sputum cytology. Cancer 2000; 89(suppl):2461-2464
8. Sturgis CD, Nassar DL, D'Antonio JA, et al. Cytological features useful for distinguishing small cell from non-small cell carcinoma in bronchial brush and washing specimen. Am J Clin Pathol 2000; 114:197-202
9. Arora VK, Singh N, Chaturvedi S, et al. Significance of cytologic criteria in distinguishing small cell from non-small cell carcinoma of lung. Acta Cytol 2003; 47:216-220
10. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest 2003; 123(suppl):115S-128S
11. Roggli VL, Sanfilippo F, Shelburne JD. Mesothelioma. In: Roggli VL, Greenberg SD, Pratt PC, eds. Pathology of asbestos: associated disease. Boston, MA: Little, Brown and Company, 1992; 109-164
12. Schwartz AM. The pathology of environmental lung disease. In: Witorsch P, Spagnolo SV, eds. Air pollution and lung disease in adults. Boca Raton, FL: CRC Press, 1994; 119-121
13. Miller BH, Rosado-de-Christenson MI, Mason AC, et al. Malignant pleural mesothelioma: radiologic-pathologic correlation. Radiographics 1966; 16:613-644
14. McCaughey WT, Colby TV, Battifora H, et al. Diagnosis of diffuse malignant mesothelioma: experience of US/Canadian mesothelioma panel. Mod Pathol 1991; 4:342-353
15. Ordonez NG. The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma. Am J Surg Pathol 2003; 27:1031-1051
16. Travis WD. Pathology of lung cancer. Clin Chest Med 2002; 23:65-81
17. Ordonez NG. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol 2000; 24:1217-1223
18. Colby TV, Koss MN, Travis WD. Small cell carcinoma and large cell neuroendocrine carcinoma. In: Tumors of the lower respiratory tract. Washington, DC: AFIP, 1994; 235-257
19. Field RW, Smith BJ, Platz CE, et al. Lung cancer histologic type in the SEER registry versus independent review. J Natl Cancer Inst 2004; 96:1105-1107
20. Colby TV, Koss MN, Travis WD. Adenocarcinoma of the lung. In: Tumors of the lower respiratory tract. Washington, DC: AFIP, 1994; 179-201
21. Colby TV, Koss MN, Travis WD. Bronchioloalveolar carcinoma. In: Tumors of the lower respiratory tract. Washington, DC: AFIP, 1994; 203-223
22. Dumont P, Gasser B, Rouge C, et al. Bronchioloalveolar carcinoma. Chest 1998; 113:391-395
23. Barsky SH, Cameron R, Osann KE, et al. Rising incidence of bronchioloalveolar carcinoma and its unique clinicopathologic features. Cancer 1994; 73:1163-1170
24. Lee KS, Kim Y, Han J, et al. Bronchioloalveolar carcinoma: clinical, histopathologic, and radiologic findings. Radiographics 1997; 17:1345-1357
25. Hecht JL, Pinkus JL, Weinstein LJ, et al. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Am J Clin Pathol 2001; 116:483-488
26. Barbareschi M, Murer B, Colby TV, et al. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol 2003; 27:141-149
27. Loy TS, Calalue RD. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Am J Clin Pathol 1994; 102:764-767
28. Nieder C, Andratschke N, Jeremic B, et al. Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancer. Anticancer Res 2003; 23:5117-5124
29. Steels E, Paesmans M, Berghmans T, et al. Role of p53 as a prognostic factor for survival in lung cancer: a systemic review of the literature with a meta-analysis. Eur Respir J 2001; 18:705-719
30. Mitsudomi T, Hamajima N, Ogawa M, et al. Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis. Clin Cancer Res 2000; 6:4055-4063
31. Thunnissen FB, Schuurbiers OC, den Bakker MA. A critical appraisal of prognostic and predictive factors for common lung cancers. Histopathology 2006; 48:779-786
32. Singhal S, Vachani A, Antin-Ozerkis D, et al. Prognostic implications of cell cycle, apoptosis, and angiogenesis: biomarkers in non-small cell lung cancer. Clin Cancer Res 2005; 11:3974-3986
33. Xi L, Coello MC, Litle VR, et al. A combination of molecular markers accurately detects lymph node metastasis in non-small cell lung cancer patients. Clin Cancer 2006; 12:2484-2491
34. Potti A, Sayan M, Petersen R, et al. A genomic strategy to refine prognosis in early-stage non-small cell lung cancer. N Engl J Med 2006; 355:570-580
35. Meert AP, Paesmans M, Martin B, et al. The role of microvessel density on survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 2002; 87:694-701
36. Chen HY, Yu SL, Chen CH, et al. A five gene signature and clinical outcome in non-small cell lung cancer. N Engl J Med 2007; 356:11-20
37. Meert AP, Martin B, Delmotte P, et al. The role of EGFR expression on patient survival in lung cancer: a systematic review with meta-analysis. Eur Respir J 2002; 20:975-981
38. Meert AP, Martin B, Paesman M, et al. The role of HER-2 expression on survival of patients with lung cancer: a systematic review of the literature. Br J Cancer 2003; 89:959-965
39. Martin B, Paesmans M, Berghmans T, et al. Role of bcl-2 as a prognostic factor for survival in lung cancer: a systemic review of the literature with meta-analysis. Br J Cancer 2003; 89:55-64
40. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small cell lung cancer to gefitinib. N Engl J Med 2004; 350:2129-2139
41. Green MR. Targeting targeted therapy [editorial]. N Engl J Med 2004; 350:2191-2193
42. Kris MG, Natale RB, Herbst RS, et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor tyrosine kinase, in symptomatic patients with non-small cell lung cancer. JAMA 2003; 290:2149-2158
43. Bell DW, Lynch TJ, Haserlat SM, et al. Epidermal growth factor receptor mutations and gene amplification in non-small cell lung cancer. J Clin Oncol 2005; 23:8081-8092
44. Buccheri G, Ferrigno D. Prognostic factors. Hematol Oncol Clin North Am 2004; 18:187-201
45. Fong KM, Minna JD. Molecular biology of lung cancer: clinical implications. Clin Chest Med 2002; 23:83-101
46. Brundage MD, Davies D, Mackillo WJ. Prognostic factors in non-small cell lung cancer. Chest 2002; 122:1037-1057
47. Ludwig MS, Goodman M, Miller DL, et al. Postoperative survival and the number of lymph nodes sampled during resection for node-negative non-small cell lung cancer. Chest 2005; 128:1545-1550
48. Little AG. Sentinel node biopsy for staining lung cancer. Surg Clin North Am 2002; 82:561-571
49. Minamiya Y, Ogawa J. The current status of sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Cardiovasc Surg 2005; 11:67-72
50. Liptay MJ. Intraoperative sentinel lymph node mapping in non-small cell lung cancer improves detection of micrometastases. J Clin Oncol 2002; 20:1984-1988
51. Faries MB, Bleicher RJ, Ye M, et al. Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms. Arch Surg 2004; 139:870-877
52. Pulte D, Crawford BK, Newman E, et al. Sentinel lymph node mapping and molecular staging in non-small cell lung carcinoma. Cancer 2005; 104:1453-1461
53. Tiffet O, Nicholson AG, Khaddage A, et al. Feasibility of the detection of the sentinel lymph node in peripheral non-small cell lung cancer with radioisotope and blue dye techniques. Chest 2005; 127:443-448
54. Marchevsky AM, Qiao JH, Krajisnik S, et al. The prognostic significance of intranodal isolated tumor cells and micrometastases in patients with non-small cell carcinoma of the lung. J Thorac Cardiovasc Surg 2003; 126:551-557
55. Jiao X, Krasna MJ. Clinical significance of micrometastasis in lung and esophageal cancer. Ann Thorac Surg 2002; 74:278-284
56. Cserni G, Bianchi S, Boecker W, et al. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer 2005; 103:358-367
57. Hermanek P, Hutter RV, Sobin LH, et al. Classification of isolated tumor cells and micrometastasis. Cancer 1999; 86:2668-2673
58. Green FL, Page D, Fleming ID, et al. AJCC cancer staging manual. 6th ed. New York, NY: Springer, 2002
59. Goldstein ND, Mani A, Chmielewski G, et al. Immunohistochemically detected micrometastases in peribronchial and mediastinal lymph nodes from patients with T1, N0, M0 pulmonary adenocarcinomas. Am J Surg Pathol 2000; 24:274-279
60. Kawano R, Hata E, Ikeda S. Micrometastasis to lymph nodes in stage I left lung cancer patients. Ann Thorac Surg 2002; 73:1558-1562
61. Gu CD, Osaki T, Oyama T, et al. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected non-small cell lung cancer. Ann Surg 2002; 235:133-139
62. Coello MC, Luketich JD, Litle V, et al. Prognostic significance of micrometastasis in non-small-cell lung cancer. Clin Lung Cancer 2004; 5:214-225
63. Tezel C, Ersev AA, Kiral H, et al. The impact of immunohistochemical detection of positive lymph nodes in early stage lung cancer. Thorac Cardiovasc Surg 2006; 54:124-128
64. Ito M, Minamiya Y, Kawai H, et al. Intraoperative detection of lymph node micrometastasis with flow cytometry in non-small cell lung cancer. J Thorac Cardiovasc Surg 2005; 130:753-758
65. Nosotti M, Falleni M, Palleschi, et al. Quantitative real-time polymerase chain reaction detection of lymph node lung cancer micrometastasis using carcinoembryonic antigen marker. Chest 2005; 128:1539-1544
66. Hashimoto T, Kobayashi Y, Ishikawa Y, et al. Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases. Cancer Res 2000; 60:6472-6478
67. Osaki T, Oyama T, Gu CD, et al. Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small-cell lung cancer. J Clin Oncol 2002; 20:2930-2936
68. Poncelet AJ, Weynand B, Ferdin F, et al. Bone marrow micrometastasis might not be a short-term predictor of survival in early stages non-small cell lung carcinoma. Eur J Cardiothorac Surg 2001; 20:481-488
69. Passlick B, Kubuschok B, Izbicki JR, et al. Isolated tumor cells in bone marrow predict reduced survival in node-negative non-small cell lung cancer. Ann Thorac Surg 1999; 68:2053-2058
70. Ohta Y, Oda M, Wu J, et al. Can tumor size be a guide for limited surgical intervention in patients with peripheral non-small cell lung cancer? Assessment from the point of view of nodal micrometastasis. J Thorac Cardiovasc Surg 2001; 122:900-906
71. Wu J, Ohta Y, Minato H, et al. Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter. Ann Thorac Surg 2001; 71:1772-1777
72. Roh MS, Lee JI, Choi PJ, et al. Relationship between micropapillary component and micrometastasis in the regional lymph nodes of patients with stage I lung adenocarcinoma. Histopathology 2004; 45:580-586
73. Ahrendt SA, Yang SC, Roig CM, et al. Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2002; 123:409-410
74. Acs G, Baloch ZW, LiVolsi VA. Intraoperative consultation: a historical perspective. Semin Diagn Pathol 2002; 19:190-191
75. Sienko A, Allen TC, Zander DS, et al. Frozen section of lung specimens. Arch Pathol Lab Med 2005; 129:1602-1609
76. Zarbo RJ, Schmidt WA, Bachner P, et al. Indications and immediate patient outcome of pathologic intraoperative consultations. Arch Pathol Lab Med 1996; 120:19-25
77. Bloustein PA, Silverberg SG. Rapid cytologic examination of surgical specimens. Pathol Annu 1977; 12:251-278
78. Wick MR, Mills SE. Evaluation of surgical margins in anatomic pathology: technical, conceptual, and clinical considerations. Semin Diagn Pathol 2002; 19:207-218
79. Motomura K, Inaji H, Komoike Y, et al. Intraoperative sentinel lymph node examination by imprint cytology and frozen section during breast cancer. Br J Surg 2000; 87:597-601
80. Hunt JL, Baloch ZW, LiVolsi VA. Sentinel lymph node evaluation for tumor metastasis. Semin Diagn Pathol 2002; 19:263-277
81. Liptay MJ, Grondin SC, Fry WA, et al. Intraoperative sentinel lymph node mapping in non-small cell lung cancer improves detection of micrometastases. J Clin Oncol 2002; 20:1984-1988
82. Oneson RH, Minke JA, Silverberg SG. Intraoperative pathologic consultation: an audit of 1000 consecutive cases. Am J Surg Pathol 1989; 13:237-243
83. Howanitz PJ, Hoffman GG, Zarbo RJ. The accuracy of frozen section diagnosis in 34 hospitals. Arch Pathol Lab Med 1990; 114:355-359
84. Zarbo RJ, Hoffman GG, Howanitz PJ. Interinstitutional comparison of frozen section consultation. Arch Pathol Lab Med 1991; 115:1187-1194
85. Zarbo RJ, Schmidt WA, Bachner P, et al. Indications and immediate patient outcome of pathology intraoperative consultations. Arch Pathol Lab Med 1996; 120:19-25
86. Sirmali M, Demirag F, Türüt H, et al. Utility of intraoperative frozen section examination in thoracic surgery: a review of 721 cases. J Cardiovasc Surg (Torino) 2006; 47:83-87
87. Raab SS, Tworek JA, Souers R, et al. The value of monitoring frozen section-permanent section correlation data over time. Arch Pathol Lab Med 2006; 130:337-342
88. Gephardt GN, Rice TW. Utility of frozen section evaluation of lymph nodes in the staging of bronchogenic carcinoma at mediastinoscopy and thoracotomy. J Thorac Cardiovasc Surg 1990; 100:853-859
89. De Montpréville VT, Dulmet EM, Nashashibi N. Frozen section diagnosis and surgical biopsy of lymph nodes, tumors and pseudotumors of the mediastinum. Eur J Cardiothorac Surg 1998; 13:190-195
90. Kontozoglou T, Cramer H. The advantages of intraoperative cytology analysis of 215 smears and review of the literature. Acta Cytol 1991; 35:154-164
91. Clarke M, Landreneau R, Borochovitz D. Intraoperative imprint cytology for evaluation of mediastinal lymphadenopathy. Ann Thorac Surg 1994; 57:1206-1210
92. Marchevsky AM, Changsri C, Gupta I, et al. Frozen section diagnoses of small pulmonary nodules: accuracy and clinical implications. Ann Thorac Surg 2004; 78:1755-1759
93. Sakai T, Hayashi N, Kimoto, et al. CT-guided biopsy of the chest: usefulness of fine-needle core biopsy combined with frozen-section pathologic diagnosis. Radiology 1994; 190:243-246
94. Thunnissen FB, den Bakker MA. Implications of frozen section analysis from bronchial resection margins in NSCLC. Histopathology 2005; 47:638-640
95. Maygarden SJ, Detterbeck FC, Funkhouser WK. Bronchial margins in lung cancer resection specimens: utility of frozen section and gross evaluation. Mod Pathol 2004; 17:1080-1086